WCCT Announces Symposium on 'Accelerating Early Clinical Development'
May 07, 2010 (PRLEAP.COM) Health NewsCypress, CA / May 7, 2010 / West Coast Clinical Trials (wcct.com) is hosting an educational symposium Tuesday, May 18, 2010 entitled, "Accelerating Early Clinical Development" at the Hilton Garden Inn, San Mateo. Representatives with unique perspectives in pharmaceutical development will provide strategies to expedite completion of early phase clinical trials. Featured presenters include physicians Dr. Paul Frohna, Dr. Richard Shames, and Dr. Anthony Fossa as well as former FDA regulatory officer, Richard Lowenthal.
According to Dr. Kenneth Kim, CEO of West Coast Clinical Trials and symposium moderator, "Professionals involved in drug development in biotechnology, venture capital, and clinical research industries will benefit the most from this presentation as the industry is challenged to develop viable drug candidates using the most expeditious value added strategy."
Topics to be discussed at one day event include: "Laying the Groundwork for a Successful Early Development Program", "Fast and Smart Drug Development", "Integrating Japan and Asia into Global Development", and "Advanced ECG Analyses in Early Clinical Development". The symposium will conclude with a panel discussion question and answer session.
Registration for the event is free. Seats are reserved on a first-come, first-served basis and are limited to the first 50 registrants. If you are interested in attending or have further questions call (714) 252-0783 or email firstname.lastname@example.org. A link to the official meeting agenda can be located here.
West Coast Clinical Trials (WCCT, wcct.com) is a privately held 120-bed clinic located in Southern California that specializes in early clinical drug development. WCCT partners with companies to help design their drug development strategy, draft protocols, and execute their phase I and phase IIa proof of concept programs. WCCT has a unique focus on ethnobridging studies along with extensive experience with healthy volunteer and specialty trials (allergy, asthma, infectious disease, pediatric, renal and vaccines).